You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

~ Buy the ISOPROPYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

ISOPROPYL ALCOHOL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for isopropyl alcohol and what is the scope of patent protection?

Isopropyl alcohol is the generic ingredient in one branded drug marketed by Zurex Pharma and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Isopropyl alcohol has sixty-five patent family members in twenty-two countries.

There is one drug master file entry for isopropyl alcohol. One supplier is listed for this compound.

Summary for ISOPROPYL ALCOHOL
International Patents:65
US Patents:7
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 384
Clinical Trials: 54
Patent Applications: 5,166
What excipients (inactive ingredients) are in ISOPROPYL ALCOHOL?ISOPROPYL ALCOHOL excipients list
DailyMed Link:ISOPROPYL ALCOHOL at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ISOPROPYL ALCOHOL
Generic Entry Date for ISOPROPYL ALCOHOL*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for ISOPROPYL ALCOHOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yaneve FongePhase 4
University of CalgaryPhase 2
State University of New York at BuffaloPhase 2/Phase 3

See all ISOPROPYL ALCOHOL clinical trials

US Patents and Regulatory Information for ISOPROPYL ALCOHOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Zurex Pharma ZURAGARD isopropyl alcohol SOLUTION;TOPICAL 210872-001 Apr 26, 2019 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ISOPROPYL ALCOHOL

Country Patent Number Title Estimated Expiration
European Patent Office 3711791 APPAREIL APPLICATEUR CUTANÉ MÉDICAL (MEDICAL SKIN APPLICATOR APPARATUS) ⤷  Sign Up
Brazil PI0606969 solução de bloqueio de cateter compreendendo citrato e um parabeno ⤷  Sign Up
European Patent Office 2986333 ⤷  Sign Up
Mexico 353841 COMPOSICIONES ANTIMICROBIANAS Y METODOS DE USO. (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE.) ⤷  Sign Up
Canada 2724784 COMPOSITIONS ANTIMICROBIENNES ET LEURS PROCEDES D'UTILISATION (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ISOPROPYL ALCOHOL

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1920764 2012/033 Ireland ⤷  Sign Up PRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN
2203462 2014029 Norway ⤷  Sign Up PRODUCT NAME: SOFOSBUVIR. (S)-ISOPROPYL 2-; NAT. REG. NO/DATE: EU/1/13/894 20140116; FIRST REG. NO/DATE: (001-002) 20140117
2447254 2018015 Norway ⤷  Sign Up PRODUCT NAME: 2-4-(N-(5,6-DIFENYLPYRAZIN-2- YL)-N- ISOPROPYLAMINO)BUTYLOKSY-N-; REG. NO/DATE: EU/1/15/1083 20160530
1448186 2012C/051 Belgium ⤷  Sign Up PRODUCT NAME: MELANGE DE CATECHOLS ISOLES D'UN EXTRAIT DE THE (CAMELLIA SINENSIS (L.) O. KUNTZE) AVEC DU MYRISTATE D'ISOPROPYLE; AUTHORISATION NUMBER AND DATE: BE424383 20120719
1448186 C300550 Netherlands ⤷  Sign Up PRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.